ArticleFrontiers in oncology2024
DenseIncepS115: a novel network-level fusion framework for Alzheimer's disease prediction using MRI images.
Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multistage feature selection and stacked generalization model for cancer detection.Scientific reports · 2025Article
- A review on computer-aided diagnostic system to classify the disorders of the gastrointestinal tract.European journal of medical research · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One of the most prevalent disorders relating to neurodegenerative conditions and dementia is Alzheimer's disease (AD). In the age group 65 and older, the prevalence of Alzheimer's disease is increasing. Before symptoms showed up, the disease had grown to a severe stage and resulted in an irreversible brain disorder that is not treatable with medication or other therapies. Therefore, early prediction is essential to slow down AD progression. Computer-aided diagnosis systems can be used as a second opinion by radiologists in their clinics to predict AD using MRI scans. In this work, we proposed a novel deep learning architecture named DenseIncepS115for for AD prediction from MRI scans. The proposed architecture is based on the Inception Module with Self-Attention (InceptionSA) and the Dense Module with Self-Attention (DenseSA). Both modules are fused at the network level using a depth concatenation layer. The proposed architecture hyperparameters are initialized using Bayesian Optimization, which impacts the better learning of the selected datasets. In the testing phase, features are extracted from the depth concatenation layer, which is further optimized using the Catch Fish Optimization (CFO) algorithm and passed to shallow wide neural network classifiers for the final prediction. In addition, the proposed DenseIncepS115 architecture is interpreted through Lime and Gradcam explainable techniques. Two publicly available datasets were employed in the experimental process: Alzheimer's ADNI and Alzheimer's classes MRI. On both datasets, the proposed architecture obtained an accuracy level of 99.5% and 98.5%, respectively. Detailed ablation studies and comparisons with state-of-the-art techniques show that the proposed architecture outperforms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.